It’s the same vaccine and UCLA has the rights to use it within trials not sponsored by NWBO. They can’t use the trademarked name and they have no ability to produce it outside clinical trials or to sell it. None. All patents and rights are owned by NWBO
Finally, in Aim 3, we will develop and validate predictive tumor, immunological and imaging biomarkers of response in recurrent glioblastoma patients enrolled in a Phase II clinical trial of DCVax-L +/- PD-1 blockade.